|Articles|June 1, 2004
Multiple studies support flexible approach to treating actinic keratoses with imiquimod
In early March, the FDA granted marketing approval for use of imiquimod cream in the treatment of nonhyperkeratotic, nonhypertrophic AKs on the scalp or face in immunocompetent individuals.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement














